UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000059050
Receipt number R000067539
Scientific Title Research on the functional and safety assessment of test food intake : Open-label study
Date of disclosure of the study information 2025/09/17
Last modified on 2025/09/10 12:53:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research on the functional and safety assessment of test food intake

Acronym

Research on the functional and safety assessment of test food intake

Scientific Title

Research on the functional and safety assessment of test food intake
: Open-label study

Scientific Title:Acronym

Research on the functional and safety assessment of test food intake
: Open-label study

Region

Japan


Condition

Condition

Healthy elementary school student

Classification by specialty

Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of the effects and safety on immune function by continuously ingestion of test food for 8 weeks.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Diary

Key secondary outcomes

Medical examination
s-IgA in saliva
Height measurement
Blood pressure
Inbody (weight, muscle mass)
Brief-type Diet History Questionnaire for 15-year-old


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Intake of test food for 8 consecutive weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

6 years-old <=

Age-upper limit

12 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Healthy elementary school students (1st to 6th grades: excluding menstrual periods)
(2) Subjects whose parents or legal guardians (hereinafter referred to as 'guardians') received a full explanation of the purpose and content of the study, fully understood it, and voluntarily provided written informed consent for the subject's participation in the study

Key exclusion criteria

(1) Subjects with a history of mental illness, diabetes, liver diseases, renal disease, gastrointestinal disease, cardiac disease, respiratory disease, peripheral vascular disease, or other serious disease.
(2) Subjects who have undergone gastrointestinal surgery.
(3) Subjects showing abnormal liver and kidney function test values.
(4) Subjects with a current medical condition. (excluding cavity treatment)
(5) Subjects who are allergic to food and drugs.
(6) Subjects who participate in strenuous sports and subjects who are trying to lose weight.
(7) Subjects with extremely irregular eating habits.
(8) Subjects who cannot stop taking health foods (including foods for specified health use and foods with functional claims) and quasi-drugs during the study period.
(9) Subjects who are continuously treated with medications (including OTC, prescription drugs).
(10) Subjects who are currently participating in other clinical studies or are scheduled to participate in research at the start of this study.
(11) Other subjects judged by the investigator or the investigator to be inappropriate for the examination.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Yumi
Middle name
Last name Takeda

Organization

Kewpie Corporation

Division name

R&D Division

Zip code

1820002

Address

2-5-7 Sengawacho, Chofu-shi, Tokyo

TEL

03-5384-7759

Email

yumi_takeda@kewpie.co.jp


Public contact

Name of contact person

1st name Makoto
Middle name
Last name Terashima

Organization

Oneness Support Co., Ltd.

Division name

Clinical Trial Division

Zip code

5300044

Address

Higashitenma building 6F, 1-7-17, Higashitenma, Kita-ku, Osaka

TEL

06-4801-8917

Homepage URL


Email

mterashima@oneness-sup.co.jp


Sponsor or person

Institute

Miura Clinic, Medical Corporation Kanonkai

Institute

Department

Personal name



Funding Source

Organization

Kewpie Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committe of Miura Clinic, Medical Corporation Kanonkai

Address

Higashitenma building 9F, 1-7-17, Higashitenma, Kita-ku, Osaka

Tel

06-6135-5200

Email

mterashima@miura-cl.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人花音会みうらクリニック(大阪府)


Other administrative information

Date of disclosure of the study information

2025 Year 09 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 08 Month 28 Day

Date of IRB

2025 Year 08 Month 28 Day

Anticipated trial start date

2025 Year 09 Month 18 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 09 Month 10 Day

Last modified on

2025 Year 09 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000067539